2-(1-金刚烷基)-2-丙醇 | 775-64-4

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-(1-金刚烷基)-2-丙醇
• 中文别名: 2-(1-金刚烷)-2-丙醇
• 英文名称: 2-(1-adamantyl)-2-propanol
• 英文别名: 2-(adamantan-1-yl)propan-2-ol；2-(1-adamantyl)-propan-2-ol；1-(1-adamantyl)-1-methylethanol；2-(1-Adamantyl)propan-2-ol
• CAS: 775-64-4
• 化学式: C₁₃H₂₂O
• mdl: MFCD00167855
• 分子量: 194.317
• InChiKey: WBKAUEBLTWRERU-UHFFFAOYSA-N

物化性质

• 熔点：
  75°C
• 沸点：
  276.2±8.0 °C(Predicted)
• 密度：
  1.070±0.06 g/cm3(Predicted)
• 保留指数：
  1515;1535;1550;1566

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2906199090
• 安全说明：
  S24/25

SDS

Name:	2-(1-Adamantyl)propan-2-ol 97% Material Safety Data Sheet
Synonym:
CAS:	775-64-4

Section 1 - Chemical Product MSDS Name:2-(1-Adamantyl)propan-2-ol 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
775-64-4	2-(1-Adamantyl)propan-2-ol	97%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 775-64-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 75 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H22O
Molecular Weight: 194

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, acrid smoke and fumes.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 775-64-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-(1-Adamantyl)propan-2-ol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 775-64-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 775-64-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 775-64-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(1-金刚烷基)-2-丙醇 在 氢氧化钾 、 potassium hydrogensulfate 、 lithium aluminium tetrahydride 、 sodium sulfite 作用下， 以 四氢呋喃 、 乙醚 、 水 为溶剂， 反应 97.0h， 生成 2-Adamantan-1-yl-2-methyl-azetidine
  参考文献：
  名称：

  Heterocyclic rimantadine analogues with antiviral activity

  摘要：

  2-(1-Adamantyl)-2-methyl-pyrrolidines 3 and 4, 2-(1-adamatityl)-2-methyl-azetidines 5 and 6, and 2-(1-adamantyl)-2-methyl-aziridines 7 and 8 were synthesized and tested for their antiviral activity against influenza A. Parent molecules 3, 5, and 7 contain the alpha-methyl-1-adimantan-methanamine 2 pharmacophoric moiety (rimantadine). The ring size effect on anti-influenza A activity was investigated. Pyrrolidine 3 was the most potent anti-influenza virus A compound, 9-fold more potent than rimantadine 2, 27-fold more potent than amantadine 1, and 22-fold more potent than ribavirin. Azetidines 5 and 6 were both markedly active against influenza A H2N2 virus, 10- to 20-fold more potent than amantadine. Aziridine 7 was almost devoid of any activity against H2N2 virus but exhibited borderline activity against H3N2 influenza A strain. Thus, it appears that changing the five-, to four- to a three-membered ring results in a drop of activity against influenza A virus. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.12.056
• 作为产物：
  描述：

  1-溴金刚烷 在 magnesium 、 1,2-二溴乙烷 作用下， 以 乙醚 为溶剂， 反应 15.25h， 生成 2-(1-金刚烷基)-2-丙醇
  参考文献：
  名称：

  Yurchenko, A. G.; Fedorenko, T. V., Journal of Organic Chemistry USSR (English Translation), 1987, vol. 23, # 5, p. 875 - 880

  摘要：

  DOI：

文献信息

• Adamantylation and Adamantylalkylation of Amides, Nitriles and Ureas in Trifluoroacetic Acid
  作者：Elvira Shokova

  DOI：10.1055/s-1997-1304

  日期：1997.9

  A new preparative method for N-adamantylation of carboxylic acid amides, ureas and for C5-adamantylation of barbituric acid in trifluoroacetic acid (TFA) is proposed. Tertiary 1-adamantanols and 1-(1-adamantyl)alkanols were used as adamantylating agents. The reaction of 1-(1-adamantyl)alkanols with nitriles in TFA solution was employed for the first time for the preparation of N-[1-(1-adamantyl)alkyl]amides.

  提出了一种在三氟乙酸（TFA）中进行羧酸酰胺、脲的N-金刚烷基化和巴比妥酸的C5-金刚烷基化的新制备方法。使用了三级的1-金刚烷醇和1-(1-金刚烷基)烷醇作为金刚烷基化试剂。首次采用了1-(1-金刚烷基)烷醇与腈在TFA溶液中的反应来制备N-[1-(1-金刚烷基)烷基]酰胺。
• Rearrangements in the adamantane series
  作者：D.J. Raber、R.C. Fort、E. Wiskott、C.W. Woodworth、P.v.R. Schleyer、J. Weber、H. Stetter

  DOI：10.1016/s0040-4020(01)92392-0

  日期：——

  ordinary Koch-Haaf carboxylation conditions the tertiary alcohol, 2-(1-adamantyl)-2-propanol (4) yields only the rearranged carboxylic acid, 3-isopropyl-1-adamantane carboxylic acid (5). Mechanistic evidence is presented which indicates that the rearrangement proceeds via intermolecular hydride shifts. A variety of synthetic approaches to the unrearranged 2-(1-adamantyl)-2-methylpropionic acid (1) are described

  当经受普通的Koch-Haaf羧化条件时，叔醇2-（1-金刚烷基）-2-丙醇（4）仅产生重排的羧酸3-异丙基-1-金刚烷羧酸（5）。提供了机械证据，其表明重排通过分子间氢化物转移进行。多种合成的接近的未重排的2-（1-金刚烷基）-2-甲基丙酸（1）中有所描述，并且成功地制备1通过的科赫-HAAF反应4高稀释条件下被报告。后面的实验证实了分子间的作用在2-（1-金刚烷基）-2-丙基阳离子（26）的重排中，氢化物转变成3-异丙基-1-金刚烷基阳离子（30）。
• Synthesis of Adamantylated Salicylic Acids
  作者：E. A. Shokova、V. V. Kovalev

  DOI：10.1134/s1070428021070095

  日期：2021.7

  synthesized by electrophilic substitution reactions of hydroxy- and bromoadamantanes with salicylic acid, as well as by reactions of 5-(3-hydroxyadamantan-1-yl)salicylic acid with carbon and nitrogen nucleophiles, in trifluoroacetic acid. The possibility of selective hydroxylation of the adamantane fragment in 5-(adamantan-1-yl)salicylic acid with sulfuric acid in trifluoroacetic anhydride has been demonstrated

  摘要 5-[3(4)-R-Adamantan-1-yl] 水杨酸 [R = H, Alk, Ar, OH, NHC(S)NH 2 ] 已通过羟基和溴金刚烷与水杨酸的亲电取代反应合成酸，以及通过 5-(3-羟基金刚烷-1-基)水杨酸与碳和氮亲核试剂在三氟乙酸中的反应。已经证明了在三氟乙酸酐中用硫酸对 5-(金刚烷-1-基)水杨酸中的金刚烷片段进行选择性羟基化的可能性。
• Approaches to primary tert-alkyl amines as building blocks
  作者：Christina Tzitzoglaki、Antonios Drakopoulos、Athina Konstantinidi、Ioannis Stylianakis、Marianna Stampolaki、Antonios Kolocouris

  DOI：10.1016/j.tet.2019.06.016

  日期：2019.8

  Primary tert-alkyl amines include analogues of amantadine, a fragment commonly linked to pharmacophoric groups to enhance biological activity. The preparation of primary tert-alkyl amines is considered to be a difficult problem. Four synthetic procedures, some of which have been previously reported for the synthesis of amines with primary (RCH2NH2) or secondary (RR'CHNH2) alkyl and/or aryl groups,

  初级叔烷基胺包括金刚烷胺的类似物，通常连接到药效基团的片段，以提高生物活性。伯叔烷基胺的制备被认为是一个难题。四个合成步骤，其中一些已经用于与胺的合成已有报道初级（RCH 2 NH 2）或仲（RR'CHNH 2）烷基和/或芳基，伯合成进行了测试叔烷基胺（RR'R''CNH 2）包括金刚烷加合物在内的脂族系列。这些程序包括在形成和还原的叔烷基叠氮化物，在标准和改良条件Ritter反应，在加入有机金属试剂以ñ -叔丁基亚磺酰基酮亚胺和一锅在路易斯酸的存在下，Τi（IPRO）腈和有机金属试剂之间的反应4或CeCl 3.对于伯叔烷基胺，尚未开发这些合成途径。当前缺乏对伯叔烷基胺的合成路线的研究。研究了每种方法的反应条件和底物限制，第一种方法是最通用的方法，也适用于带有大分子加合物的化合物。
• Zn-Mediated Hydrodeoxygenation of Tertiary Alkyl Oxalates
  作者：Hegui Gong、Yang Ye、Guobin Ma、Ken Yao

  DOI：10.1055/a-1328-0352

  日期：2021.10

  Herein we describe a general, mild, and scalable method for hydrodeoxygenation of readily accessible tertiary alkyl oxalates by Zn/silane under Ni-catalyzed conditions. The reduction method is suitable for an array of structural motifs derived from tertiary alcohols that bear diverse functional groups, including the synthesis of a key intermediate en route to estrone.

  本文中，我们描述了在Ni催化条件下通过Zn /硅烷对易获得的叔烷基草酸酯进行加氢脱氧的一般，温和和可扩展的方法。还原方法适用于衍生自带有不同官能团的叔醇的一系列结构基序，包括在通往雌酮的途中合成关键中间体。